Zentalis Pharmaceuticals
ZNTL
ZNTL
116 hedge funds and large institutions have $64.5M invested in Zentalis Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 44 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $92.9M → $64.5M (-$28.4M)
43% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 37
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $73K
Holders
116
Holding in Top 10
2
Calls
–
Puts
$73K
Top Buyers
| 1 | +$1.28M | |
| 2 | +$928K | |
| 3 | +$780K | |
| 4 |
Two Sigma Investments
New York
|
+$717K |
| 5 |
TCM
Tybourne Capital Management
Hong Kong
|
+$681K |
Top Sellers
| 1 | -$3.28M | |
| 2 | -$1.38M | |
| 3 | -$973K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$940K |
| 5 |
DC
Decheng Capital
Menlo Park,
California
|
-$919K |